Skip to content
Back to announcement

20231116_SDPC_Laporan Informasi dan Fakta Material_31520076_lamp1.pdf

Other Text extracted SDPC

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1 OCR 0.921
PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

No. 1 516/MPI/DIR/XI/2023 Jakarta, 16 November 2023
Lampiran : -

Perihal : Laporan Informasi atau Fakta Material

Yth.

Kepala Eksekutif

Pengawas Pasar Modal

Otoritas Jasa Keuangan

Gedung Soemitro Djojohadikusumo
Jalan Lapangan Banteng Timur 2-4
Jakarta 10710

Sehubungan dengan Peraturan Otoritas Jasa Keuangan (OJK) no : 31/POJK.04/2015 tanggal
16 Desember 2015 tentang Keterbukaan Informasi atas Fakta Material oleh Emiten atau Perusahaan
Publik dan Surat Keputusan Direksi PT Bursa Efek Indonesia No. Kep-00066/BEI/09-2022 tanggal
30 September 2022 perihal Perubahan Peraturan Nomor I-E tentang Kewajiban Penyampaian
Informasi, dengan ini kami menyampaikan Laporan Informasi atau Fakta Material sebagai berikut:

In reference to Otoritas Jasa Keuangan (OJK) Regulation No.: 31/POJK.04/2015 dated 16" December
2015 regarding Disclosure Information of Material Fact by Issuer or Public Company and PT Bursa
Efek Indonesia's Board of Director Decree No. Kep-00066/BEN/09-2022 dated 30" September 2022
regarding to the Changes on the Provision No. I-E regarding Obligation of Information Submission,
we hereby disclose the information and Material Fact as follow:

Nama Emiten atau Perusahaan Publik//ssuer: PT Millennium Pharmacon International Tbk

(“Perseroan”)
Bidang Usaha/Scope of Business 1 Distribusi produk farmasi, suplemen makanan dan alat
kesehatan
Telepon/Phone 1 (021)2708 5961, (021) 2708 5964
Faksimili/Facsimile 1 (021) 2708 5958
Alamat surat elektronik/e-mail 1  investor.relation@mpi-pharmaniaga.co.id
1 | Tanggal kejadian Date Event |
14 November 2023 November 14", 2023
2 | Jenis Informasi atau Fakta Material Type of Information or Material Facts

Penandatanganan — Perjanjian Perubahan | Signing of Amendmeni to Credit Facility
Terhadap Fasilitas Kredit

|

3 | Uraian Informasi atau Fakta Material Description of Information or Material Facts |
a) Pihak-pihak yang melakukan perjanjian: | a) Parties to the agreement: Company and PT |
Perseroan dan PT Bank CIMB Niaga Tbk, Bank CIMB Niaga Tbk: |

b) Perubahan yang dilakukan antara lain | b) The said amendment in relation changes on |
merubah struktur fasilitas BG menjadi the BG facility to be standalone credit |

fasilitas kredit dengan limit terpisah facility with PTK Trade AP and changes on
(standalone) dengan fasilitas PTK Trade AP the credit limit total to IDR 360,000,000,000

serta perubahan atas limit kredit menjadi (three hundred sixty billion Rupiah):
Crown Bungur-Arteri-2-4th-Ftoors TP
Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia RACE EA
Phone : 46221 27085961 Fax : 46221 27085958 MEMBER

Page 2 OCR 0.910
MPI

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

total Rp 360.000.000.000, - (tiga ratus enam
puluh miliar Rupiah),

4 | Dampak kejadian, informasi atau fakta
material tersebut terhadaj kegiatan
operasional, hukum, kondisi keuangan, atau

kelangsungan usaha Emiten atau
Perusahaan Publik

Fasilitas Kredit ini memperkuat modal kerja dan
dapat menunjang kegiatan usaha Perseroan.

Impact for such information or material fact
towards operational activity, legal, financial
condition or business continuity of Issuer or
Public Company

This Credit Facility strengthens the working
capital and supports the Company's business
activities.

5 | Keterangan lain-lain Other Information
|| Tidak ada None |
Hormat kami,

PT Millennium Pharmacon International Tbk

PHARMACON INTERNATIONAL Tok

Nama: Ahmad bin|Abu Bakar
Jabatan: Direktur Utama

Tembusan:
PT Bursa Efek Indonesia
u.p. Yth. Direksi

Crown Bungur Arteri 2-4th Floors
Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia
Phone : #6221 27085961 Fax : #6221 27085958

12

kanan

) sos

File

File Open PDF
Source IDX
Size0.46 MB
Published16 Nov 2023
Pages2
Characters3,687
Text sourceOCR
OCR confidence0.916

Names mentioned 0 people and organisations named in the text · linked when the evidence is strong

The name pass has not read this document yet.

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 1

↑↓ select ↵ open ⇧↵ see every result